An Amplifier for Diagnostic Tests

Sword Diagnostics of Illinois has developed a “next-generation” system to increase the sensitivity (and therefore accuracy) of diagnostic tests.

Read more »

Ovatech Leaves the Hormones Out of Birth Control

Ovatech of Auburndale, Mass., is developing the world’s first non-hormonal, female-controlled contraception device.

Read more »

Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform

Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.

Read more »

The Universal Vaccines of Inovio Biomedical

Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.

Read more »

Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator

Inovio Biomedical (AMEX: INO) is developing a robust pre-clinical and early clinical stage pipeline of innovative DNA-based vaccines and therapeutics that target cancer, influenza, and other infectious diseases (e.g. HIV) based on its SynCon DNA vaccine construct and electroporation DNA delivery technology platforms.

Read more »

Potential Breakthrough in Search for AIDS Vaccine

Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS.

Read more »

Special Report: Fighting the U.S. AIDS Epidemic

An estimated 1.2 million people in the U.S. have the HIV virus. OneMedPlace speaks with AIDS advocate Michael Manganiello about the scope of the epidemic, the possibility of a vaccine, and what needs to happen to make a national AIDS strategy a reality.

Read more »

GlaxoSmithKline, Pfizer Team Up Against HIV

The collaboration of two pharmaceutical giants may mark the beginning of an industry shift. Pfizer and GlaxoSmithKline are combining their HIV drug businesses into a single, jointly owned company that will account for almost 20 percent of the market.

Read more »

[Video Profile] Inovio Biomedical Corporation

Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV.

Read more »